The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2025

Filed:

Dec. 03, 2018
Applicant:

Illumina, Inc., San Diego, CA (US);

Inventors:

Vitor Ferreira Onuchic, San Diego, CA (US);

Kristina M. Kruglyak, San Diego, CA (US);

Assignee:

Illumina, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G16H 50/20 (2018.01); C12Q 1/6806 (2018.01); C12Q 1/6809 (2018.01); C12Q 1/6827 (2018.01); C12Q 1/6886 (2018.01); G06F 17/15 (2006.01); G16B 20/10 (2019.01); G16B 20/20 (2019.01); G16B 40/00 (2019.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G16H 50/20 (2018.01); C12Q 1/6806 (2013.01); C12Q 1/6809 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6886 (2013.01); G06F 17/153 (2013.01); G16B 20/10 (2019.02); G16B 20/20 (2019.02); G16B 40/00 (2019.02); G16H 50/30 (2018.01);
Abstract

Computer implemented methods and computer systems are provided for estimating cancer cell fractions indicating proportions of cancer cells carrying one or more mutations of interest using one or more nucleic acid samples from a subject. The methods and systems provided herein implement processes that use a variational Bayesian mixture model to cluster initial cancer cell fractions and obtain the one or more final cancer cell fractions, the initial cancer cell fractions accounting for cancer purity and copy numbers. The disclosed methods and systems improve accuracy, validity, and reliability of tests for cancer clonality, and save time, materials, cost, and computer resources required for the tests, which can help design more affective cancer treatments.


Find Patent Forward Citations

Loading…